Vasomedical, Inc.OTCPK - Current
Jan. 7, 2015, 10:08 AM
- Vasomedical (OTCQB:VASO -2.4%) subsidiary Vaso Diagnostics (d/b/a Vaso Healthcare) extends its sales representation agreement with GE Healthcare until December 31, 2018. Under the terms of the agreement, VasoHealthcare is the exclusive sales representative for select GE Healthcare diagnostic imaging products to specific market segments in the U.S. and District of Columbia. The original contract was signed on May 19, 2010.
Nov. 12, 2014, 1:32 PM
- Vasomedical (OTCQB:VASO): Q3 Net Loss of $0.12M.
- Revenue of $7.64M (+0.4% Y/Y).
Aug. 13, 2014, 10:35 AM
- Vasomedical (OTCQB:VASO) Q2 results: Revenues: $7.9M (-0.4%); Net Loss: ($0.2M) (+67.2%); Quick Assets: $22.4M (-13.8%).
- No financial guidance given.